Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

The term 'neuromyelitis optica spectrum disorders'(NMOSD) is used as an umbrella term that
refers to aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica (NMO) …

The spectrum of MOG-IgG-associated disease (MOGAD) includes optic neuritis (ON),
myelitis (MY), acute disseminated encephalomyelitis (ADEM), brainstem encephalitis …

Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) is a spectrum of diseases,
including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and …

Background and Objectives Although the diagnosis of myelin oligodendrocyte glycoprotein
antibody-associated disease (MOGAD) is based on serum MOG antibodies (MOG-Abs) …

New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) have recently been proposed, distinguishing this syndrome from other …

Spinal cord involvement can be observed in the course of immune-mediated disorders.
Although multiple sclerosis (MS) represents the leading cause of inflammatory myelopathy …

The term neuromyelitis optica spectrum disorder (NMOSD) describes a group of clinical-MRI
syndromes characterized by longitudinally extensive transverse myelitis, optic neuritis …

Objective The aim of this study was to assess the diagnostic utility of cerebrospinal fluid
(CSF) myelin oligodendrocyte glycoprotein antibodies (MOG‐IgG) testing. Methods We …